Dangbei Neo review: A mini projector with massive potential Dangbei release their new Netflix-certified projector, the Neo which does a little of everything but does have some limitations Daily Mirror · Jun 9, 2023
Bryan Caplan on NIMBYism and Economic Ignorance Leading expert on political ignorance and housing comments on evidence indicating that ignorance, not self-interest, is at the root of most opposition to zoning reform. Reason · May 31, 2023
3D X-DRAM Roadmap: 1Tb Die Density by 2030 3D X-DRAM from NEO Semiconductor uses technology inspired by 3D NAND. The firm's roadmap sees the arrival of 1Tb DRAM dies by 2030. Tom’s Hardware · May 4, 2023
The Parent Company Q3 Revenue Drops 28% Sequentially, CEO Says New Products Coming Soon The Parent Company (NEO: GRAM.U) (OTCQX: GRAMF) announced its financial results on Monday for the quarter ended September 30, 2022 ("Q3 2022"). “All amounts are expressed in U.S. dollars,” reads a press release. Benzinga · Nov 15, 2022
If You Invested $1,000 In These 3 Crypto Tokens You Would Have This Much In Crypto Dividends When navigating the cryptocurrency market it can be difficult to distinguish between the “s— tokens” and tokens that actually provide value through a utility. Benzinga · Oct 28, 2022
Satellite images show North Korea may be building deadly new ballistic missile submarine North Korea could be planning to launch a new submarine capable of firing ballistic missiles, says think tank 38 North, citing satellite images showing a submarine construction quay Daily Mirror · Sep 22, 2022
1 Stock to Buy This Week and 1 Stock to Dump Investors’ sentiment is significantly mixed at the moment, with market volatility at its peak. It could be wise to buy quality stock Vertex Pharmaceuticals (VRTX), which possesses robust financials. However, fundamentally weak stock NeoGenomics (NEO) is best avoided now. Read on…. StockNews.com · Aug 1, 2022
4 Stocks That Just Went From Bad To Worse Stagflation is the word of the hour, with reckless inflation and aggressive interest rate hikes leading to slashed growth estimates. Our proprietary rating system recently downgraded MicroStrategy (MSTR), NeoGenomics (NEO), SolarEdge (SEDG), and Block (SQ) from Sell to Strong Sell. So, these stocks are best avoided now. Read on…. StockNews.com · Jun 27, 2022
3 Stocks That Just Went From Bad To Worse Surging inflation and the Fed’s continued interest rate hikes have kept equities under pressure lately, driving the S&P 500 index into bearish territory. Given this backdrop, fundamentally weak stocks Boxed (BOXD), KalVista Pharmaceuticals (KALV), and NeoGenomics (NEO) are best avoided now. These stocks were downgraded from ‘Sell’ to ‘Strong Sell’… StockNews.com · Jun 21, 2022
MindMed Appoints Schond L. Greenway As CFO Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO. Benzinga · May 23, 2022
TILT Holdings Q1 Revenue Down 22% Sequentially To $42.4M, $55 Million In Leaseback Transaction TILT Holdings Inc. (NEO: NEO) (OTCQX: TLLTF) reported its financial and operating results for the three months ended March 31, 2022. Benzinga · May 16, 2022
Why Neo Performance Materials Shares Are Surging Today Neo Performance Materials Inc (TSX:NEO) (OTC:NOPMF) reported first-quarter revenue growth of 27.1% year-over-year to $166.28 million. Adjusted EPS improved to $0.56 from $0.39 in 1Q21. Volumes saw a decline of 16.6% Y/Y, reflecting the recent spike in COVID-19 in Asia, several natural disasters that impacted production facilities and customers, and the ongoing… Benzinga · May 13, 2022
Trees Secures Funding For Acquisition Of Camp Cannabis Retail Stores In Ontario, Closes Private Placement Of Shares Trees Corporation (NEO: TREE) has closed a non-brokered private placement of its 34.17 million at $0.03 per unit for gross proceeds of approximately $1.03 million. Under the private placement, each unit is comprised of one common share and one-half of one common share purchase warrant of the company. Benzinga · May 9, 2022
Analyst Ratings for NeoGenomics Analysts have provided the following ratings for NeoGenomics (NASDAQ:NEO) within the last quarter: Benzinga · Apr 28, 2022
Chicago Sun-Times · Apr 27, 2022 The Mix: Cool things to do in Chicago April 28-May 4 “Lookingglass Alice,” the One of a Kind spring show, and “Jersey Boys” are among the entertainment highlights in the week ahead.
Benzinga · Apr 27, 2022 NeoGenomics: Q1 Earnings Insights NeoGenomics (NASDAQ:NEO) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Bangkok Post · Apr 20, 2022 Hopes high for QSNCC as Apec summit approaches N.C.C. Management & Development expects the 2022 Apec summit in Thailand to draw at least 30,000 visitors to the new Queen Sirikit National Convention Center (QSNCC).
Benzinga · Apr 13, 2022 Dash, Stacks Among Top Crypto Movers In 24H According to Benzinga Pro, the following are the crypto gainers and losers at the time of publication:
Benzinga · Mar 29, 2022 Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.
Benzinga · Mar 29, 2022 Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space The psychedelics legislative landscape continues to move forward with Hazel Park, Michigan enacting decriminalization measures for naturally-produced psychedelic molecules, becoming the third city in the state to do so after Ann Arbor and Detroit. In Utah, Governor Cox signed a psychedelics research bill into law and positive legislation around psilocybin is continuing…
Benzinga · Mar 29, 2022 Why NeoGenomics Stock Is Plunging Today NeoGenomics Inc's (NASDAQ:NEO) CEO Mark Mallon will step down as CEO and member of the Board, effective immediately. The Board has retained Russell Reynolds to search for the Company's next CEO The Board has appointed current Chair Lynn Tetrault, Esq. as Executive Chair and established an Interim Office of the CEO. Read…
Benzinga · Mar 29, 2022 10 Biggest Price Target Changes For Tuesday BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.
Benzinga · Mar 29, 2022 Where NeoGenomics Stands With Analysts Over the past 3 months, 8 analysts have published their opinion on NeoGenomics (NASDAQ:NEO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Benzinga · Mar 29, 2022 The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia Here's a roundup of top developments in the biotech space over the last 24 hours:
Benzinga · Mar 28, 2022 MindMed Reports Full Year 2021 Financial Results, Announces Changes In Leadership Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED) reported its financial results for the full year ended December 31, 2021. 2021 Financial Results Cash balance as of December 31, 2021, was $133.5 million compared to $80.1 million as of December 31, 2020. Net cash in operating activities was $45.8 million for…